Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

Projects / Programmes source: ARIS

Early neurodevelopmental treatment

Edit
Research activity

Code Science Field Subfield
3.03.00  Medical sciences  Neurobiology   
Evaluation (rules)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Researchers (4)
no. Code Name and surname Research area Role Period No. of publications
1.  21592  PhD Katja Groleger Sršen  Public health (occupational safety)  Researcher  2002 - 2004  0 
2.  11515  PhD Marta Macedoni Lukšič  Neurobiology  Researcher  2002 - 2004  0 
3.  09180  PhD David Neubauer  Oncology  Head  2002 - 2004  0 
4.  08292  PhD Anton Zupan  Neurobiology  Researcher  2002 - 2004  0 
Organisations (2)
no. Code Research organisation City Registration number No. of publications
1.  0309  University Rehabilitation Institute, Republic of Slovenia  Ljubljana  5053919000  0 
2.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  125 
Abstract
The study will include newborns with risk facturs according to criteria of Mercuri et al. (12). During the first week of life the following investigations will be added to the standard ones: clinical neurological examination, video-assessment of general movements (GMs) and ultrasound brain scan. A follow-up will include video assessment GMs according to protocol of Prechtl et al. (6). Children with abnormal patterns of GMs will be included in neurodevelopmental treatment (NDT)- Bobath approach in randomised way: first group will be treater once and the second one twice a week. A small group of children will be also recorded just before and after therapy to evaluate short-term effect. Not treat children will be followed up as control group. To evaluate effectiveness of therapy followed methods/tests will be done: neurological and development examination, Denver Screener Test II, Bayley Developmental Screener Test, Gross Motor Function Measure (GMFM), Pediatric Evaluation of Disability Inventory (PEDI), Gross Motor Function Classification System (GMFCS). Clinical Adaptive Test and Clinical Linguistic Auditory Milestone Scal will be included as psychological (cognitive) evaluation.
Confirmation required
Views history
Favourite